ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 787

Cardiovascular Risk Factors and Incident Giant Cell Arteritis

Gunnar Tomasson1, Jóhannes Björnsson2, Vilmundur Gudnason3, Yuqing Zhang4 and Peter A. Merkel5, 1Dept of Public Health Sciences, University of Iceland, Reykiavik, Iceland, 2Department of Pathology, Akureyri Hospital, Akureyri, Iceland, 3The Icelandic Heart Association, Kopavogur, Iceland, 4Boston University School of Medicine, Boston, MA, 5University of Pennsylvania, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess the effect of cardiovascular risk factors on incidence GCA within a longitudinal cohort study in which detailed information on cardiovascular risk factors has been collected.

Methods: The data source is the Reykjavik Study (RS), a population-based, prospective cohort study with a primary focus on cardiovascular disease.  All persons born in 1907-1935 that were living in Reykjavik, Iceland or adjacent communities on December 1, 1967 were invited to participate.  Subjects came for a study visit in 1967-1996 and information on cardiovascular risk factors, including smoking habits, blood pressure, diabetes, body mass index, and serum cholesterol was obtained.  All temporal artery biopsies (TABs) obtained from 1961-2009 on members of the cohort were identified through all three pathology laboratories in Iceland.  All TABs were re-examined in a standardized fashion by a single pathologist with expertise in vascular pathology. Incidence of GCA was calculated for exposed (GCA) and unexposed (no GCA) subjects and incidence rate ratios (IRR) were calculated with 95% confidence intervals adjusted for age and sex.

Results: Data were obtained from 19,241 subjects that were followed for a median 23.1 (IQR: 17.6-29.4) years after the age of 50.  During the follow-up of 444,396 person-years, 194 subjects had GCA, corresponding to an incidence rate of 45.0 (95% CI: 38.8-51.2) per 100,000 person-years after the age of 50. Woman had increased incidence of GCA compared to men, IRR= 2.03 (95% CI: 1.49 – 2.76).  BMI was inversely associated with GCA; subjects with a BMI>25 had an IRR= 0.68 (95% CI: 0.50-0.90).  Smoking was inversely associated with GCA among men IRR= 0.51 (95% CI: 0.30-0.86), but not women IRR=1.12 (95% CI: 0.79-1.57). Hypertension was associated with incident GCA among men IRR= 1.91 (95% CI: 1.12-3.25), but not among women IRR= 0.86 (95% CI: 0.60-1.24).  Serum cholesterol was not associated with incident GCA.

Conclusion: This study confirms a high incidence of GCA in Iceland.  Lower BMI is associated with the occurrence of GCA. Among men, hypertension is positively associated with GCA and smoking is inversely associated with incident GCA.


Disclosure:

G. Tomasson,
None;

J. Björnsson,
None;

V. Gudnason,
None;

Y. Zhang,
None;

P. A. Merkel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-factors-and-incident-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology